Yeast coexpression of human papillomavirus types 6 and 16 capsid proteins

被引:12
|
作者
Buonamassa, DT
Greer, CE
Capo, S
Yen, TSB
Galeotti, CL
Bensi, G
机构
[1] Chiron SpA, IRIS, Dept Mol Biol, I-53100 Siena, Italy
[2] Chiron Corp, Vaccine Res, Emeryville, CA 94608 USA
[3] Vet Adm Med Ctr, Dept Pathol, San Francisco, CA 94121 USA
[4] Univ Calif San Francisco, San Francisco, CA 94121 USA
关键词
papillomavirus; capsid proteins; VLP assembly; yeast expression;
D O I
10.1006/viro.2001.1289
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The L1 and L2 capsid proteins of animal and human papillomaviruses (HPVs) can self-assemble into virus-like particles (VLPs) that closely resemble native virions. The use of different animal models shows that VLPs can be very efficient at inducing a protective immune response. However, studies with infectious HPV virions and VLPs of different HPV types indicate that the immune response is predominantly type-specific. We have generated a diploid yeast strain that coexpresses the L1 and L2 capsid proteins of both HPV-6b and HPV-16, and we have purified fully assembled VLPs banding in a cesium chloride gradient at the expected density of 1.29-1.3 mg/ml. Experimental evidence strongly indicated that the four proteins coassembled into VLPs. Western blot analysis, using anti-HPV-6 and anti-HPV-16 L1-specific monoclonal antibodies and type-specific L2 antisera, demonstrated that all four proteins copurified, Most importantly, immunoprecipitation experiments, carried out using type-specific anti-L1 monoclonals and either total yeast cell extracts or purified VLPs, confirmed the interaction and the formation of covalent disulfide bonds between the two L1 proteins. Finally, HPV-6/16 VLPs administered to mice induced conformational antibodies against both L1 protein types. These results suggest that coexpression of different capsid proteins may provide new tools for the induction of antibodies directed against multiple HPV types. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:335 / 344
页数:10
相关论文
共 50 条
  • [21] Differential antibody responses to a distinct region of human papillomavirus minor capsid proteins
    Embers, ME
    Budgeon, LR
    Culp, TD
    Reed, CA
    Pickel, MD
    Christensen, ND
    VACCINE, 2004, 22 (5-6) : 670 - 680
  • [22] Human Papillomavirus Types by Age in Cervical Cancer Precursors: Predominance of Human Papillomavirus 16 in Young Women
    Porras, Carolina
    Rodriguez, Ana Cecilia
    Hildesheim, Allan
    Herrero, Rolando
    Gonzalez, Paula
    Wacholder, Sholom
    Burk, Robert D.
    Schiffman, Mark
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (03) : 863 - 865
  • [23] Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine (Gardasil®):: Profile report
    Siddiqui, M. Asif A.
    Perry, Caroline M.
    BIODRUGS, 2006, 20 (05) : 313 - 316
  • [24] Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18
    Villa, Luisa L.
    Ault, Kevin A.
    Giuliano, Anna R.
    Costa, Ronaldo L. R.
    Petta, Carlos A.
    Andrade, Rosires P.
    Brown, Darron R.
    Ferenczy, Alex
    Harper, Diane M.
    Koutsky, Laura A.
    Kurman, Robert J.
    Lehtinen, Matti
    Malm, Christian
    Olsson, Sven-Eric
    Ronnett, Brigitte M.
    Skjeldestad, Finn Egil
    Steinwall, Margareta
    Stoler, Mark H.
    Wheeler, Cosette M.
    Taddeo, Frank J.
    Yu, Jimmy
    Lupinacci, Lisa
    Railkar, Radha
    Marchese, Rocio
    Esser, Mark T.
    Bryan, Janine
    Jansen, Kathrin U.
    Sings, Heather L.
    Tamms, Gretchen M.
    Saah, Alfred J.
    Barr, Eliav
    VACCINE, 2006, 24 (27-28) : 5571 - 5583
  • [25] Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis
    Song, S
    Liem, A
    Miller, JA
    Lambert, PF
    VIROLOGY, 2000, 267 (02) : 141 - 150
  • [26] Prevalence of Human papillomavirus Types 6, 11, 16, 18, 31, and 33 in a Cohort of Greek Women
    Panotopoulou, Efstathia
    Tserkezoglou, Aliki
    Kouvousi, Maria
    Tsiaousi, Ioanna
    Chatzieleftheriou, George
    Daskalopoulou, Demitra
    Magiakos, George
    JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (12) : 1898 - 1905
  • [27] Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia
    Newall, Anthony T.
    Brotherton, Julia M. L.
    Quinn, Helen E.
    McIntyre, Peter B.
    Backhouse, Josephine
    Gilbert, Lynn
    Esser, Mark T.
    Erick, Joanne
    Bryan, Janine
    Formica, Neil
    MacIntyre, C. Raina
    CLINICAL INFECTIOUS DISEASES, 2008, 46 (11) : 1647 - 1655
  • [28] A Major Role for the Minor Capsid Protein of Human Papillomavirus Type 16 in Immune Escape
    Fahey, Laura M.
    Raff, Adam B.
    Da Silva, Diane M.
    Kast, W. Martin
    JOURNAL OF IMMUNOLOGY, 2009, 183 (10): : 6151 - 6156
  • [29] Sequence variation in the capsid protein genes of human papillomavirus type 16 and type 31
    Icenogle, JP
    Clancy, KA
    Lin, SY
    VIROLOGY, 1995, 214 (02) : 664 - 669
  • [30] A deletion and point mutation study of the human papillomavirus type 16 major capsid gene
    Varsani, Arvind
    Williamson, Anna-Lise
    Jaffer, Mohamed A.
    Rybicki, Edward P.
    VIRUS RESEARCH, 2006, 122 (1-2) : 154 - 163